
Industry Audit and Company of The year.



Professional Scientific StaffingSM Solutions - Lancaster Whitepaper




PharmRep 2010 sworn statement




GSK is being ordered to pay $2.5 million in restitution to a Pennsylvania family. The firm was accused of not doing enough to warn consumers that taking the antidepressant Paxil, while pregnant, could lead to birth defects.

Sandoz Shire Pharmaceuticals announced that it would allow Sandoz to market a generic version of its blockbuster ADHD med Adderall XR if it can clear FDA. But that's a big if.



12 October

Pharmaceutical Executive
Sure, industry growth is at "historically low levels," but at least pharma is still growing. The industry's market value should surpass $825 billion in 2010, and forecasted growth was bumped up one percentage point from original estimates.

Meet Pharm Exec?s 2009 Emerging Leaders?27 industry pioneers under age 45 who are bringing new ideas to life - 09 emerging leaders

Pharmaceutical Executive
Pulling off an incredibly fast turnaround, the pharma industry has released a vaccine for the H1N1 virus, bolstering its bottom line with a second flu vaccine and potentially helping millions of people. So why is there such an uproar over whether it's safe?


An increasing pressure to get products to market means more data must be handled within a shorter time span. But how?

05 October

Pharmaceutical Executive
Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.

Pharmaceutical Executive
Game-changers can create competitive advantages for pharmaceutical companies and products.

01 October 2009

Pharmaceutical Executive
Just months on the job and GSK’s new president of North American Pharmaceuticals Deirdre Connelly is already making her presence known. Her latest move-spearheading an initiative that will boost funding to autonomous CME programs and cut commercial medical education programs. Pharm Exec spoke with Connelly to find out more.

June 2009 BPA Statement

Takeda's Dr Erich Brunn tells Pharm Exec Europe why now is the right time for the Japanese giant to get really serious about Europe.

"If you don't like change, you are going to like irrelevance even less." Gen Eric Shinseki US Army (ret.)